Clinical and biological manifestations in primary parvovirus B19 infection in immunocompetent adult: A retrospective study of 26cases;Manifestations cliniques et biologiques de la primo-infection à parvovirus B19chez l'adulte immunocompétent: Étude rétrospective de 26observations

Revue de Medecine Interne

Volumn 35, Issue 5, 2014, Pages 289-296

  Parra, D ^a,b   Mekki, Y ^c   Durieu, I ^d   Broussolle, C ^a,b   Seve P ^a,b  

^a CROIX ROUSSE HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Adult; Autoantibodies; Immunocompetent; Lupus; Parvovirus B19

Indexed keywords

ACUTE PHASE PROTEIN; ANTINUCLEAR ANTIBODY; CYTOMEGALOVIRUS ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY;

ABDUCENS NERVE PARALYSIS; ABNORMAL LABORATORY RESULT; ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISTAL PARESTHESIA; ERYTHEMA INFECTIOSUM; FEVER; HUMAN; HUMAN PARVOVIRUS B19; HYPERTRANSAMINASEMIA; HYPOCOMPLEMENTEMIA; IMMUNOCOMPROMISED PATIENT; LYMPHOCYTOPENIA; MICROBIOLOGICAL EXAMINATION; MYOCARDITIS; PARAPROTEINEMIA; PERSISTENT INFECTION; RASH; RETROSPECTIVE STUDY; SEROLOGY; SEX DIFFERENCE; SEX RATIO; SYMPTOM; THROMBOCYTOPENIA; ADOLESCENT; AUTOIMMUNITY; FEMALE; IMMUNOCOMPETENCE; IMMUNOLOGY; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PATHOGENICITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUTOIMMUNITY; FEMALE; HUMANS; IMMUNOCOMPETENCE; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84899480996     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2013.04.015     Document Type: Article

References (52)

1. Cossart Y.E., Field A.M., Cant B., Widdows D. Parvovirus-like particles in human sera. Lancet 1975, 1:72-73.
2. Dennert R., Crijns H.J., Heymans S. Acute viral myocarditis. Eur Heart J 2008, 29:2073-2082.
3. Douvoyiannis M., Litman N., Goldman D.L. Neurologic manifestations associated with parvovirus B19infection. Clin Infect Dis 2009, 48:1713-1723.
4. Hillingsø J.G., Jensen I.P., Tom-Petersen L. Parvovirus B19and acute hepatitis in adults. Lancet 1998, 351:955-956.
5. Waldman M., Kopp J.B. Parvovirus B19and the Kidney. Clin J Am Soc Nephrol 2007, 2(Suppl. 1):47-56.
6. Barlow G.D., McKendrick M.W. Parvovirus B19causing leucopenia and neutropenia in a healthy adult. J Infect 2000, 40:192-195.
7. Meyer O. Parvovirus B19et maladies auto-immunes B19. Rev Rhu 2003, 70:9-15.
8. Cathébras P., Robert F., Guglielminotti C., Bonnevial L., Rousset H. Primo-infection à parvovirus B19chez l'adulte immunocompétent: variété d'expression clinique et biologique. Étude rétrospective de 16patients. Rev Med Interne 2000, 21:324-329.
9. Hayakawa H., Tara M., Niina K., Osame M. A clinical study of adult human parvovirus B19infection. Intern Med 2002, 41:295-299.
10. Oiwa H., Shimada T., Hashimoto M., Kawaguchi A., Ueda T., Sugiyama E., et al. Clinical findings in parvovirus B19infection in 30adult patients in Kyoto. Mod Rheumatol 2011, 21:24-31.
11. Kerr J.R., Coyle P.V., DeLeys R.J., Patterson C.C. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19infection. J Med Virol 1996, 48:68-75.
12. Woolf A.D., Campion G.V., Chishick A., Wise S., Cohen B.J., Klouda P.T., et al. Clinical manifestations of human parvovirus B19in adults. Arch Intern Med 1989, 149:1153-1156.
13. de Oliveira S.A., Camacho L.A.B., de M Pereira A.C., Faillace T.F., Setubal S., do Nascimento J.P. Clinical and epidemiological aspects of human parvovirus B19infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil). Mem Inst Oswaldo Cruz 2002, 97:965-970.
14. Waza K., Inoue K., Matsumura S. Symptoms associated with parvovirus B19infection in adults: a pilot study. Intern Med 2007, 46:1975-1978.
15. Mossong J., Hens N., Friederichs V., Davidkin I., Broman M., Litwinska B., et al. Parvovirus B19infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 2008, 136:1059-1068.
16. Billette de Villemeur A., Gratacap-Cavallier B., Casey R., Baccard-Longère M., Goirand L., Seigneurin J.M., et al. Occupational risk for cytomegalovirus, but not for parvovirus B19in child-care personnel in France. J Infect 2011, 63:457-467.
17. Varache S., Narbonne V., Jousse-Joulin S., Guennoc X., Dougados M., Daurès J.P., et al. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6weeks? Results from a nationwide longitudinal prospective cohort study. Arthritis Care Res 2011, 63:1565-1570.
18. Moore T.L. Parvovirus-associated arthritis. Curr Opin Rheumatol 2000, 12:289-294.
19. Söderlund-Venermo M., Hokynar K., Nieminen J., Rautakorpi H., Hedman K. Persistence of human parvovirus B19in human tissues. Pathol Biol 2002, 50:307-316.
20. Narvaez J., Nolla J.M., Valverde J. Absence de preuve sérologique sur un lien entre fibromyalgie et exposition au parvovirus B19. Rev Rhum 2005, 72:1354-1356.
21. Vassilopoulos D., Calabrese L.H. Virally associated arthritis: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther 2008, 10:215.
22. Hashimoto H., Yuno T. Parvovirus B19-associated purpuric-petechial eruption. J Clin Virol 2011, 52:269-271.
23. Imbert B., Brion J.P., Janbon B., Gonzales M., Micoud M. Érythème noueux associé à une infection par le parvovirus B19. Presse Med 1989, 18:1753-1754.
24. Fortna R.R., Toporcer M., Elder D.E., Junkins-Hopkins J.M. A case of sweet syndrome with spleen and lymph node involvement preceded by parvovirus B19infection, and a review of the literature on extracutaneous sweet syndrome. Am J Dermatopathol 2010, 32:621-627.
25. Lenglet T., Haroche J., Schnuriger A., Maisonobe T., Viala K., Michel Y., et al. Mononeuropathy multiplex associated with acute parvovirus B19infection: characteristics, treatment and outcome. J Neurol 2011, 258:1321-1326.
26. Scheibe F., Hofmann J., Ruprecht K. Parainfectious myelitis associated with parvovirus B19infection. J Neurol 2010, 257:1557-1558.
27. Rabar D., Peyramond D. Dysesthésies prolongées révélant une primo-infection à Parvovirus B19. Med Mal Infect 2005, 35:91-94.
28. Le Scanff J., Vighetto A., Mekki Y., Nguyen A.M., Dufour J.F., Broussolle C., et al. Acute ophthalmoparesis associated with human parvovirus B19infection. Eur J Ophthalmol 2010, 20:802-804.
29. Bültmann B.D., Klingel K., Sotlar K., Bock C.T., Baba H.A., Sauter M., et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 2003, 34:92-95.
30. Trochu J.N., Piriou N., Toquet C., Bressollette C., Valleix F., Le Tourneau T., et al. Myocardites. Rev Med Interne 2012, 33:567-574.
31. Basic D., Gupta S., Kwong R.Y. Parvovirus B19-induced myocarditis mimicking acute myocardial infarction: clarification of diagnosis by cardiac magnetic resonance imaging. Circulation 2010, 121:40-42.
32. Bock C.T., Klingel K., Kandolf R. Human parvovirus B19-associated myocarditis. N Engl J Med 2010, 362:1248-1249.
33. Stewart G.C., Lopez-Molina J., Gottumukkala RVSRK, Rosner G.F., Anello M.S., Hecht J.L., et al. Myocardial parvovirus B19persistence: lack of association with clinicopathologic phenotype in adults with heart failure. Circ Heart Fail 2011, 4:71-78.
34. Chisaka H., Morita E., Yaegashi N., Sugamura K., Parvovirus B19and the pathogenesis of anaemia. Rev Med Virol 2003, 13:347-359.
35. Hession M.T., Au S.C., Gottlieb A.B. Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction?. J Rheumatol 2010, 37:2430-2432.
36. Sève P., Ferry T., Charhon A., Calvet A., Broussolle C. Manifestations systémiques des infections à Parvovirus B19. Rev Med Interne 2004, 25:740-751.
37. Michot J.M., Hié M., Galicier L., Lambotte O., Michel M., Bloch-Queyrat C., et al. Le syndrome d'activation lymphohistiocytaire de l'adulte. Rev Med Interne 2013, 34:85-93.
38. Krygier D.S., Steinbrecher U.P., Petric M., Erb S.R., Chung S.W., Scudamore C.H., et al. Parvovirus B19induced hepatic failure in an adult requiring liver transplantation. World J Gastroenterol 2009, 15:4067-4069.
39. Mogensen T.H., Jensen J.M.B., Hamilton-Dutoit S., Larsen C.S. Chronic hepatitis caused by persistent parvovirus B19infection. BMC Infect Dis 2010, 10:246.
40. Soloninka C.A., Anderson M.J., Laskin C.A. Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19. J Rheumatol 1989, 16:777-781.
41. Sène D., Piette J.C., Cacoub P. Anticorps antiphospholipide, syndrome des anticorps antiphospholipides et infections virales. Rev Med Interne 2009, 30:135-141.
42. Aslanidis S., Pyrpasopoulou A., Kontotasios K., Doumas S., Zamboulis C. Parvovirus B19infection and systemic lupus erythematosus: activation of an aberrant pathway?. Eur J Intern Med 2008, 19:314-318.
43. Sève P., Ferry T., Koenig M., Cathebras P., Rousset H., Broussolle C. Lupus-like presentation of parvovirus B19infection. Semin Arthritis Rheum 2005, 34:642-648.
44. Ramos-Casals M., Cuadrado M.J., Alba P., Sanna G., Brito-Zerón P., Bertolaccini L., et al. Acute viral infections in patients with systemic lupus erythematosus: description of 23cases and review of the literature. Medicine (Baltimore) 2008, 87:311-318.
45. Seishima M., Shibuya Y., Watanabe K., Kato G. Pericarditis and pleuritis associated with human parvovirus B19infection in a systemic lupus erythematosus patient. Mod Rheumatol 2010, 20:617-620.
46. Zakrzewska K., Corcioli F., Carlsen K.M., Giuggioli D., Fanci R., Rinieri A., et al. Human parvovirus B19 (B19V) infection in systemic sclerosis patients. Intervirology 2009, 52:279-282.
47. De Stefano R., Manganelli S., Frati E., Selvi E., Azzi A., Zakrzewska K., et al. No association between human parvovirus B19infection and Sjögren's syndrome. Ann Rheum Dis 2003, 62:86-87.
48. Weis P.J., Demarco P.J., Pischel K.D. Can parvovirus B19infection trigger adult Still's disease? Report of a case controlled with infliximab. J Clin Rheumatol 2001, 7:277-279.
49. Lidar M., Lipschitz N., Langevitz P., Shoenfeld Y. The infectious etiology of vasculitis. Autoimmunity 2009, 42:432-438.
50. Hermann J., Demel U., Stünzner D., Daghofer E., Tilz G., Graninger W. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19infection as a pitfall. Ann Rheum Dis 2005, 64:641-643.
51. Berth M., Bosmans E. Acute parvovirus B19infection frequently causes false-positive results in Epstein-Barr virus -and Herpes simplex virus- specific immunoglobulin M determinations done on the liaison platform. Clin Vaccine Immunol 2009, 16:372-375.
52. Bernstein D.I., El Sahly H.M., Keitel W.A., Wolff M., Simone G., Segawa C., et al. Safety and immunogenicity of a candidate parvovirus B19vaccine. Vaccine 2011, 29:7357-7363.